Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity.
about
An update on lupus animal models.Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases.IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
P2860
Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective IRAK4 Inhibition Att ...... ates Steroid Sparing Activity.
@en
Selective IRAK4 Inhibition Att ...... ates Steroid Sparing Activity.
@nl
type
label
Selective IRAK4 Inhibition Att ...... ates Steroid Sparing Activity.
@en
Selective IRAK4 Inhibition Att ...... ates Steroid Sparing Activity.
@nl
prefLabel
Selective IRAK4 Inhibition Att ...... ates Steroid Sparing Activity.
@en
Selective IRAK4 Inhibition Att ...... ates Steroid Sparing Activity.
@nl
P2093
P2860
P50
P356
P1476
Selective IRAK4 Inhibition Att ...... ates Steroid Sparing Activity.
@en
P2093
Ajay Saxena
Deborah A Holloway
Durga Shiv Prasad
John Duncia
John Hynes
Joseph Santella
Julie A Carman
Kamala Venkatesh
Kim W McIntyre
P2860
P304
P356
10.4049/JIMMUNOL.1600583
P407
P50
P577
2016-12-21T00:00:00Z